 |
 |
 |
 |
 |
increase font size
Natco the pharmaceutical company from India that has been licensed by Gilead to manufacture the generic version of Harvoni, is the first company in India to receive from the Indian government the permit to manufacture the generic version of the Sovaldi that will market under the name of Hepcinat.
This generic Sovaldi will be sold in the 91 countries that are part of the program that the company created to grant access to the medicine in developing countries.
The main component of
this medicine is a good alternative to Sovaldi that has show its efficacy in the treatments of patients infected with the virus of Hepatitis C genotypes 1,2,3, and 4
The price of Hepcinat is much more affordable than the branded version Sovaldi.
